by admin_63069 | Feb 19, 2020 | Related Topics
Recently presented data suggests Rubraca may play a meaningful role in the treatment of patients with BRCA 1/2 mutant recurrent, metastatic castrate-resistant prostate cancer.
by admin_63069 | Feb 12, 2020 | Related Topics, Uncategorized
Scientific report published on February 12, 2020
by admin_63069 | Feb 5, 2020 | Related Topics
Read this January 21, 2020 article by a News Reporter-Staff News Editor at Cancer Daily.
by admin_63069 | Feb 1, 2020 | Related Topics
A five-year follow-up study of 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices regarding...
by admin_63069 | Jan 27, 2020 | Related Topics
An article by a News Reporter-Staff News Editor at Health and Medicine Business Daily
by admin_63069 | Jan 16, 2020 | Related Topics
Read this article by Danielle Ternyila published in Targeted Oncology.
